| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |